Tri-Luma was not permanently banned or pulled from the market for safety reasons. The prescription melasma cream has experienced repeated and prolonged shortages over the years, leaving many patients unable to find it at pharmacies. These supply disruptions appear tied to manufacturing and product stability challenges rather than a formal FDA recall or safety withdrawal.
What Actually Happened to Tri-Luma
Tri-Luma is a triple-combination cream that blends a mild steroid, a skin-lightening agent (hydroquinone at 4%), and a retinoid. It remains FDA-approved and is still listed as a prescription product. But “FDA-approved” and “available at your pharmacy” are two different things, and Tri-Luma has spent long stretches being extremely difficult or impossible to get.
One documented issue involves the cream’s stability. Galderma, the manufacturer, changed Tri-Luma’s required storage temperature from a standard “not exceeding 25°C” (roughly room temperature) to a much colder 2 to 8°C, which is refrigerator temperature. That kind of change signals the product was degrading faster than expected under normal conditions. A cream that must be refrigerated throughout its entire supply chain, from factory to warehouse to pharmacy to your home, is significantly harder and more expensive to distribute than one that sits on a shelf at room temperature. This cold-chain requirement likely contributed to supply disruptions and may have made the product less commercially viable for the manufacturer.
No FDA-approved generic version of Tri-Luma exists, which means there is no alternative manufacturer to pick up the slack when the brand-name product is unavailable. If Galderma pauses or slows production for any reason, the product simply disappears from pharmacy shelves.
Hydroquinone’s Regulatory Shift
Part of the confusion around Tri-Luma’s availability stems from broader regulatory changes to hydroquinone, its key skin-lightening ingredient. The FDA ruled that hydroquinone products are not approved for over-the-counter sale. Dozens of non-prescription hydroquinone creams vanished from store shelves as a result, and many people assumed prescription products like Tri-Luma were caught up in the same sweep.
They weren’t. Prescription hydroquinone products, including Tri-Luma, remain legal. Your dermatologist can still prescribe hydroquinone at 4% or higher concentrations. The OTC ban removed the lower-strength creams (typically 2%) that were previously sold without a prescription, but it did not affect Tri-Luma’s FDA approval status. The timing of these regulatory changes overlapping with Tri-Luma’s supply problems, however, made it easy to conflate the two issues.
Known Side Effects and Safety Profile
While safety concerns did not cause Tri-Luma’s disappearance, the cream does carry a meaningful side effect profile that’s worth understanding. In clinical trials, 41% of users experienced redness, 38% had skin peeling, 18% reported burning, and 14% dealt with dryness. About 11% experienced itching. Less common reactions included acne (5%), visible tiny blood vessels called telangiectasia (3%), and pigment changes (2%).
The three active ingredients each carry their own risks. The steroid component can thin the skin with prolonged use and, in rare cases, cause systemic effects if absorbed in large amounts. The retinoid component causes skin irritation and is unsafe during pregnancy. Hydroquinone, the lightening agent, carries a small risk of a condition called exogenous ochronosis, where the skin paradoxically darkens with a bluish-gray discoloration, typically after extended or excessive use. This is why Tri-Luma was always intended for short treatment courses, usually eight weeks, rather than ongoing use.
What’s Available Now
Tri-Luma remains on the FDA’s approved drug list as a prescription-only product. Whether you can actually fill a prescription depends on current manufacturing status and pharmacy stock, which has fluctuated unpredictably. There is no FDA-approved generic equivalent, so you cannot substitute a cheaper version.
If you can’t find Tri-Luma, dermatologists commonly prescribe its three ingredients separately: a hydroquinone cream, a tretinoin cream, and a mild topical steroid, used in sequence. Some compounding pharmacies will also mix a similar triple combination to order. These workarounds lack the convenience of a single tube and haven’t been tested in the same clinical trials, but they use the same active ingredients at comparable strengths and are widely used in practice.
Other prescription options for melasma that avoid hydroquinone entirely include tranexamic acid (taken orally or applied topically) and azelaic acid creams. These work through different mechanisms and may be worth discussing with a dermatologist if Tri-Luma remains out of reach or if you prefer to avoid hydroquinone altogether.